Sander G. Mills

5.8k total citations
77 papers, 2.6k citations indexed

About

Sander G. Mills is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sander G. Mills has authored 77 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 26 papers in Organic Chemistry and 20 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sander G. Mills's work include Neuropeptides and Animal Physiology (17 papers), Receptor Mechanisms and Signaling (14 papers) and Sphingolipid Metabolism and Signaling (11 papers). Sander G. Mills is often cited by papers focused on Neuropeptides and Animal Physiology (17 papers), Receptor Mechanisms and Signaling (14 papers) and Sphingolipid Metabolism and Signaling (11 papers). Sander G. Mills collaborates with scholars based in United States, United Kingdom and Germany. Sander G. Mills's co-authors include Richard Desmond, Peter Beak, Malcolm MacCoss, Robert A. Reamer, Jeffrey J. Hale, Todd K. Jones, Margaret A. Cascieri, R. P. Volante, I. Shinkai and Sharon Sadowski and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Immunology and Biochemistry.

In The Last Decade

Sander G. Mills

77 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sander G. Mills United States	30	1.2k	1.2k	381	304	257	77	2.6k
John W. Clader United States	28	953 0.8×	1.4k 1.2×	227 0.6×	320 1.1×	325 1.3×	72	3.1k
William J. Greenlee United States	34	2.2k 1.8×	2.0k 1.7×	642 1.7×	251 0.8×	124 0.5×	161	4.5k
Donmienne Leung United States	18	1.2k 1.0×	545 0.5×	411 1.1×	332 1.1×	283 1.1×	26	2.9k
Donald S. Karanewsky United States	30	1.8k 1.5×	1.1k 0.9×	218 0.6×	362 1.2×	65 0.3×	77	3.0k
Michael E. Hodsdon United States	27	1.6k 1.3×	330 0.3×	233 0.6×	380 1.3×	73 0.3×	59	2.4k
Joseph A. Kozlowski United States	26	732 0.6×	1.1k 1.0×	319 0.8×	282 0.9×	58 0.2×	69	2.4k
Zoran Ranković United States	23	2.3k 1.9×	1.4k 1.2×	666 1.7×	366 1.2×	54 0.2×	67	4.0k
Jean‐Pierre Hénichart France	30	1.8k 1.5×	1.7k 1.4×	365 1.0×	428 1.4×	77 0.3×	198	3.6k
John Saunders United States	28	1.3k 1.0×	1.3k 1.1×	410 1.1×	226 0.7×	33 0.1×	139	3.1k
Mark G. Bock United States	29	1.9k 1.6×	1.8k 1.5×	875 2.3×	330 1.1×	148 0.6×	109	3.8k

Countries citing papers authored by Sander G. Mills

Since Specialization

Citations

This map shows the geographic impact of Sander G. Mills's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sander G. Mills with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sander G. Mills more than expected).

Fields of papers citing papers by Sander G. Mills

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sander G. Mills. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sander G. Mills. The network helps show where Sander G. Mills may publish in the future.

Co-authorship network of co-authors of Sander G. Mills

This figure shows the co-authorship network connecting the top 25 collaborators of Sander G. Mills. A scholar is included among the top collaborators of Sander G. Mills based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sander G. Mills. Sander G. Mills is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Songnian, Lihu Yang, Sander G. Mills, et al.. (2015). Design, synthesis, and biological evaluation of aminopyrazine derivatives as inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). Bioorganic & Medicinal Chemistry Letters. 25(22). 5402–5408. 9 indexed citations

Walsh, Shawn P., Changyou Zhou, Jiafang He, et al.. (2011). 3-Substituted 3-(4-aryloxyaryl)-propanoic acids as GPR40 agonists. Bioorganic & Medicinal Chemistry Letters. 21(11). 3390–3394. 20 indexed citations

Tang, Haifeng, Zhe Feng, Lihu Yang, et al.. (2010). Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activities. Bioorganic & Medicinal Chemistry Letters. 20(20). 6088–6092. 13 indexed citations

Pasternak, Alexander, Mary Struthers, Pasquale P. Vicario, et al.. (2009). Discovery of a Potent and Orally Bioavailable CCR2 and CCR5 Dual Antagonist. ACS Medicinal Chemistry Letters. 1(1). 14–18. 25 indexed citations

Lin, Songnian, Jeffrey J. Hale, Sander G. Mills, et al.. (2009). Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas as potent inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). Bioorganic & Medicinal Chemistry Letters. 19(12). 3238–3242. 18 indexed citations

Yang, Lihu, et al.. (2008). An expeditious synthesis of 3-(difluoromethoxy)- and 3-(trifluoromethoxy)-5,6,7,8-tetrahydro-1,6-naphthyridines. Tetrahedron Letters. 49(44). 6368–6370. 11 indexed citations

Lin, Peter, Robert J. DeVita, Jonathan R. Young, et al.. (2007). The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidine. Bioorganic & Medicinal Chemistry Letters. 17(18). 5191–5198. 11 indexed citations

Schröder, Carsten, Richard N. Pierson, Bao-Ngoc Nguyen, et al.. (2007). CCR5 Blockade Modulates Inflammation and Alloimmunity in Primates. The Journal of Immunology. 179(4). 2289–2299. 48 indexed citations

Yang, Lihu, Gabor Butora, Changyou Zhou, et al.. (2007). Discovery of 3-Piperidinyl-1-cyclopentanecarboxamide as a Novel Scaffold for Highly Potent CC Chemokine Receptor 2 Antagonists. Journal of Medicinal Chemistry. 50(11). 2609–2611. 24 indexed citations

10.

Young, Jonathan R., Robert J. DeVita, Marc M. Kurtz, et al.. (2007). Pyrrolidine-carboxamides and oxadiazoles as potent hNK1 antagonists. Bioorganic & Medicinal Chemistry Letters. 17(19). 5310–5315. 16 indexed citations

11.

Yang, Lihu, Changyou Zhou, Liangqin Guo, et al.. (2006). Discovery of 3,5-bis(trifluoromethyl)benzyl l-arylglycinamide based potent CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(14). 3735–3739. 20 indexed citations

12.

Plummer, Christopher W., Paul E. Finke, Sander G. Mills, et al.. (2005). Synthesis and activity of 4,5-diarylimidazoles as human CB1 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 15(5). 1441–1446. 46 indexed citations

13.

Shah, Shrenik K., Natalie Chen, Sander G. Mills, et al.. (2005). Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butane. Bioorganic & Medicinal Chemistry Letters. 15(4). 977–982. 22 indexed citations

14.

Hale, Jeffrey J., William Neway, Sander G. Mills, et al.. (2004). Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720. Bioorganic & Medicinal Chemistry Letters. 14(12). 3351–3355. 64 indexed citations

15.

Meurer, Laura C., Paul E. Finke, Sander G. Mills, et al.. (2004). Synthesis and SAR of 5,6-diarylpyridines as human CB1 inverse agonists. Bioorganic & Medicinal Chemistry Letters. 15(3). 645–651. 27 indexed citations

16.

Hale, Jeffrey J., Christopher L. Lynch, William Neway, et al.. (2004). A Rational Utilization of High-Throughput Screening Affords Selective, Orally Bioavailable 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonists. Journal of Medicinal Chemistry. 47(27). 6662–6665. 65 indexed citations

17.

Finke, Paul E., Laura C. Meurer, Bryan Oates, et al.. (2001). Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: A proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butanes. Bioorganic & Medicinal Chemistry Letters. 11(18). 2469–2473. 31 indexed citations

18.

Finke, Paul E., Bryan Oates, Sander G. Mills, et al.. (2001). Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure–Activity relationships for 1-[N-(Methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanes. Bioorganic & Medicinal Chemistry Letters. 11(18). 2475–2479. 62 indexed citations

19.

Cascieri, Margaret A., Elżbieta Ber, Tung M. Fong, et al.. (1997). Characterization of the binding and activity of a high affinity, pseudoirreversible morpholino tachykinin NK1 receptor antagonist. European Journal of Pharmacology. 325(2-3). 253–261. 8 indexed citations

20.

Heathcock, Clayton H., Steven K. Davidsen, Sander G. Mills, & Mark A. Sanner. (1986). Total synthesis of (.+-.)-methyl homodaphniphyllate. Journal of the American Chemical Society. 108(18). 5650–5651. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact